🌎 American Express Upgraded, Saia Upgraded, Whirlpool Initiated and more...

Ratings changes for Coinbase Global, Eos Energy Enterprises, NetApp, Wingstop, TG Therapeutics, BranchOut Food, Check Point Software Technologies and more...Text "MarketBeat" to  68285  to get SMS breaking news alerts for stocks on your watchlist and other special reports.  Learn More. Unsubscribe. View My Portfolio July 13th, 2026     Zacks just upgraded BNZI - here is what drove the call (Ad) Banzai International (NASDAQ: BNZI) just received a Zacks Rank 2 (Buy) upgrade, driven by improving earnings estimate revisions and growing analyst confidence in its AI-powered sales and marketing platform. With gross margins above 80%, a $5.5 million annualized cost reduction program already underway, $7.4 million in year-to-date debt reduction, and a new distribution alliance with Ingram Micro, BNZI is aligning multiple catalysts heading into Q3.   See why BNZI may be worth adding to your watchlist now Today's Top Stories 3 Overlooked Stocks Positioned for the Next Market Rotation By Bridget Bennett  |  July 13, 2026 07:35 AM You Won’t Get a Warning Before This Correction Hits  (Ad) By StockEarnings 3 Non-Tech Stocks Still Winning Big on AI By Nathan Reiff  |  July 13, 2026 07:00 AM Power Struggle: Wolfspeed Sues Navitas Over AI Chips By Jeffrey Neal Johnson  |  July 11, 2026 08:40 AM He bet half his $9 billion on ONE stock  (Ad) By Stansberry Research Pushing the Edge: Super Micro Computer Reboots the AI Landscape By Jeffrey Neal Johnson  |  July 11, 2026 06:55 AM Rocket Lab’s Stock Drop Comes With a Bullish Twist By Ryan Hasson  |  July 10, 2026 09:35 AM Quick Links Analyst RatingsMy MarketBeatAccount SettingsMarketBeat All AccessStock ListsStock ScreenerCalculatorsPremium ReportsBest Stocks to Buy in July BioStem files Form 10 in move toward Nasdaq uplisting (Ad) BioStem Technologies (OTC: BSEM) has publicly filed a Form 10 registration statement with the SEC, advancing its progress toward a planned Nasdaq uplisting. CEO Jason Matuszewski says the filing is expected to enhance credibility, expand capital access, and improve market visibility. BioStem is a regenerative medicine company commercializing perinatal tissue allograft products via its proprietary BioRetain, CryoTek, and SteriTek processing technologies.   Read the full press release to learn what comes next for BSEM Your Watchlist Manage Your Watchlist and Monitor Your Portfolio   Apple Inc. (AAPL) $321.16 +5.84 (+1.85%)  As of 7/13/2026 9:37 AM ET U.S.-Iran Tensions, AI Memory Pullback, AAPL Suing OpenAI Adds Pressure to Start Week 7/13 - youtube Apple Stock Trending After Suing OpenAI for Allegedly Stealing Hardware Trade Secrets 7/13 - benzinga Iran strikes, Lindsey Graham, Apple takes OpenAI to court and more in Morning Squawk 7/13 - cnbc Why Apple sued OpenAI: everything to know about the AI trade secrets lawsuit 7/13 - invezz Apple Sues OpenAI Over Alleged Hardware Trade Secret Theft 7/13 - blockonomi   Amazon.com, Inc. (AMZN) $247.52 +2.18 (+0.89%)  As of 7/13/2026 9:37 AM ET Jeff Bezos Backed Grail Before It Lost Half Its Value. Here's Whether He Was Early -- or Just Wrong. 7/13 - fool AI Data Center Spending Is Outpacing Every Forecast on Wall Street. These 2 Stocks Are the Best Pick-and-Shovel Plays. 7/13 - fool Amazon's AI Chip Bet Could Be Bigger Than Investors Realize 7/13 - fool Elon Musk Says He Was "Clearly Wrong" About Anthropic's Artificial Intelligence (AI) Models. Here's Why That's Outstanding News for Amazon and Alphabet Investors. 7/13 - fool Y Intercept Hong Kong Ltd Sells 36,982 Shares of Amazon.com, Inc. $AMZN 7/13 - marketbeat   Alphabet Inc. (GOOGL) $355.95 -1.23 (-0.35%)  As of 7/13/2026 9:37 AM ET Alphabet Inc (GOOGL) Stock: Looking Beyond the $4.7 Billion EU Fine 7/13 - insidermonkey Over 200 experts call for urgent action to tackle AI's economic impact 7/13 - yahoo Ranking the "Magnificent 7" Stocks by Free-Cash-Flow Yield 7/13 - fool V Square Quantitative Management LLC Trims Stock Position in Alphabet Inc. $GOOGL 7/13 - marketbeat Value Investment Professionals LLC Sells 8,781 Shares of Alphabet Inc. $GOOGL 7/13 - marketbeat   Meta Platforms, Inc. (META) $665.74 -3.47 (-0.52%)  As of 7/13/2026 9:37 AM ET Meta Scales Up Louisiana AI Data Center 7/13 - wsj Meta AI Splurge Continues and J.P. Morgan Is Worried for the Stock 7/13 - barrons Meta Lifts Cost of Louisiana Data Center to $50 Billion 7/13 - wsj Meta expands Louisiana data center to 5 gigawatts compute capacity 7/13 - reuters Meta's Louisiana data center investment to reach $50 billion, aided by generous tax incentives 7/13 - cnbc   Microsoft Corporation (MSFT) $388.80 +3.70 (+0.96%)  As of 7/13/2026 9:37 AM ET ‘Portfolios are becoming much riskier’: How to make defensive investments before the AI bubble pops 7/13 - yahoo Apple’s $600 Billion Rally Fueled by Traders Fleeing AI Selloff 7/13 - yahoo Elon Musk Says He Was "Clearly Wrong" About Anthropic's Artificial Intelligence (AI) Models. Here's Why That's Outstanding News for Amazon and Alphabet Investors. 7/13 - fool MSFT Class Alert: Microsoft Misrepresentations about Copilot Functionality Issues Under Review in Securities Fraud Class Action – Contact BFA Law if You Lost Money 7/13 - globenewswire Ranking the "Magnificent 7" Stocks by Free-Cash-Flow Yield 7/13 - fool Manage Your Watchlist Analysts' Upgrades American Express (NYSE:AXP) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $400.00 price target on the stock, up from $328.00. This represents a 12.4% upside from the current price of $355.78. Casey's General Stores (NASDAQ:CASY) was upgraded by Northcoast Research from "neutral" to "buy". They now have a $950.00 price target on the stock. This represents a 13.5% upside from the current price of $836.81. Saia (NASDAQ:SAIA) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $502.00 price target on the stock, up from $499.00. This represents a 17.9% upside from the current price of $425.85. Verra Mobility (NASDAQ:VRRM) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral". They now have a $6.00 price target on the stock, up from $5.00. This represents a 29.0% upside from the current price of $4.65. View More Upgrades 82.1% win rate on IPOs - free session this Wednesday (Ad) With SpaceX's record IPO behind us and Forbes warning of an 'IPO tsunami' hitting Wall Street, trading veteran Larry Benedict is stepping forward with a strategy he has used 95 times since 2022 at a documented 82.1% win rate. This Wednesday, July 15 at 8 p.m. ET, Larry is hosting a free live session to show investors how to potentially pocket $321, $1,605, or more on IPO day from one five-minute trade - without ever owning a share of the newly public company.   Reserve your free seat for Larry Benedict's IPO strategy session now How to profit on IPO day without buying a single share (Ad) Trading veteran Larry Benedict has placed the same IPO-day trade 95 times since 2022, logging a documented 82.1% win rate - without ever buying a single share of the stock going public. On Wednesday, July 15, at 8 p.m. ET, Larry is hosting a free live session where he'll reveal the exact ticker behind the trade, how to potentially pocket hundreds or thousands on IPO day, and how one little-known clause can give traders two separate profit windows from a single IPO. With over 800 IPOs expected to hit the market, the next opportunity window could open within days.   Reserve your free seat for Larry Benedict's July 15 strategy session Analysts' New Coverage Apyx Medical (NASDAQ:APYX) is now covered by HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock. This represents a 60.7% upside from the current price of $4.36. Candel Therapeutics (NASDAQ:CADL) is now covered by Stifel Nicolaus. They set a "buy" rating and a $22.00 price target on the stock. This represents a 137.6% upside from the current price of $9.26. First Carolina Financial Services (NYSE:FCBM) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $15.00 price target on the stock. This represents a 18.6% upside from the current price of $12.65. Glass House Brands (NYSE:GLAS) is now covered by Lake Street Capital. They set a "buy" rating and a $17.00 price target on the stock. This represents a 43.8% upside from the current price of $11.83. Kardigan (NASDAQ:KARD) is now covered by Leerink Partners. They set an "outperform" rating and a $37.00 price target on the stock. This represents a 50.2% upside from the current price of $24.64. Kardigan (NASDAQ:KARD) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $51.00 price target on the stock. This represents a 107.0% upside from the current price of $24.64. Liftoff Mobile (NASDAQ:LFTO) is now covered by Tigress Financial. They set a "buy" rating and a $39.00 price target on the stock. This represents a 60.2% upside from the current price of $24.34. NervGen Pharma (NASDAQ:NGEN) is now covered by Leerink Partners. They set an "outperform" rating and a $10.00 price target on the stock. This represents a 403.8% upside from the current price of $1.99. NLS Pharmaceutics (NASDAQ:NCEL) is now covered by Laidlaw. They set a "buy" rating and a $23.00 price target on the stock. This represents a 448.9% upside from the current price of $4.19. Park Aerospace (NYSE:PKE) is now covered by Needham & Company LLC. They set a "buy" rating and a $43.00 price target on the stock. This represents a 22.0% upside from the current price of $35.25. Spruce Biosciences (NASDAQ:SPRB) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $160.00 price target on the stock. This represents a 215.2% upside from the current price of $50.76. Walt Disney (NYSE:DIS) is now covered by Benchmark Co.. They set a "buy" rating and a $115.00 price target on the stock. This represents a 18.5% upside from the current price of $97.02. West Pharmaceutical Services (NYSE:WST) is now covered by BNP Paribas Exane. They set an "outperform" rating and a $447.00 price target on the stock. This represents a 25.8% upside from the current price of $355.23. Whirlpool (NYSE:WHR) is now covered by BNP Paribas Exane. They set a "neutral" rating and a $43.00 price target on the stock. This represents a 4.8% upside from the current price of $41.02. Whitehawk Therapeutics (NASDAQ:WHWK) is now covered by Leerink Partners. They set an "outperform" rating and a $9.00 price target on the stock. This represents a 129.6% upside from the current price of $3.92. View More New Coverage Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Thank you for subscribing to MarketBeat! We empower investors to make better investment decisions by delivering real-time financial information and unbiased investment analysis.   If you need assistance with your newsletter, please don't hesitate to email MarketBeat's U.S. based support team at contact@marketbeat.com.   If you would like to opt out or modify which newsletters you receive, you can modify your subscription preferences or unsubscribe from these emails.   © 2006-2026 MarketBeat Media, LLC. 345 North Reid Place, Sixth Floor, Sioux Falls, S.D. 57103. U.S.A..   Further Reading: Zacks just upgraded BNZI - here is what drove the call (From Huge Alerts)